Ozempic vs Rybelsus: Price & Results Breakdown (2026)
Trying to choose between Ozempic (Semaglutide) and Rybelsus (Semaglutide (oral))? Below we put the trial weight loss numbers, monthly cost, dosing, and tolerability head to head — and spell out the type of patient each one tends to fit best.
Ozempic (Semaglutide) and Rybelsus (Semaglutide (oral)) both work as GLP-1 receptor agonists but differ in formulation and dosing. Ozempic is FDA-approved for type 2 diabetes, while Rybelsus is approved for type 2 diabetes. Average weight loss: 8-14% of body weight (Ozempic) vs 5-10% of body weight (Rybelsus).
The Numbers at a Glance
| Feature | Ozempic | Rybelsus |
|---|---|---|
| Active Ingredient | Semaglutide | Semaglutide (oral) |
| Mechanism | GLP-1 receptor agonist | GLP-1 receptor agonist |
| FDA Approved For | Type 2 diabetes | Type 2 diabetes |
| Doses | 0.25mg, 0.5mg, 1mg, 2mg (weekly injection) | 3mg, 7mg, 14mg (daily oral tablet) |
| Administration | Weekly subcutaneous injection | Daily oral tablet on empty stomach |
| Avg. Weight Loss | 8-14% of body weight | 5-10% of body weight |
| Monthly Price | $998 | $936 |
| Oral Available | No | Yes |
| Year Approved | 2017 | 2019 |
- Ozempic
- Semaglutide
- Rybelsus
- Semaglutide (oral)
- Ozempic
- GLP-1 receptor agonist
- Rybelsus
- GLP-1 receptor agonist
- Ozempic
- Type 2 diabetes
- Rybelsus
- Type 2 diabetes
- Ozempic
- 0.25mg, 0.5mg, 1mg, 2mg (weekly injection)
- Rybelsus
- 3mg, 7mg, 14mg (daily oral tablet)
- Ozempic
- Weekly subcutaneous injection
- Rybelsus
- Daily oral tablet on empty stomach
- Ozempic
- 8-14% of body weight
- Rybelsus
- 5-10% of body weight
- Ozempic
- $998
- Rybelsus
- $936
- Ozempic
- No
- Rybelsus
- Yes
- Ozempic
- 2017
- Rybelsus
- 2019
Figures shown are typical cash-pay prices before insurance. What you pay can differ by pharmacy, region, and your specific plan. Last updated March 2026.
Which Drops More Weight?
Based on clinical data, Ozempic produces more weight loss on average (8-14% of body weight) compared to Rybelsus (5-10% of body weight). They act on the body in much the same way, but formulation and dosing differences nudge the results apart.
Cleared first for type 2 diabetes management, it is frequently prescribed off-label to support weight loss. Its active drug, semaglutide, is identical to what powers Wegovy.
The original GLP-1 medication taken by mouth. Because its dosing runs below injectable semaglutide, weight loss is more modest, but it suits anyone who would rather swallow a tablet than inject.
Which Is Easier on Your Wallet?
At list price, Rybelsus is the more affordable option at $936/month compared to $998/month for Ozempic. That said, what leaves your pocket swings hugely with your coverage. Ozempic with insurance: $25-$200/month typical copay. Rybelsus with insurance: $10-$150/month typical copay.
Introductory cash-pay rate from Novo Nordisk: $199/month
Savings programs from the manufacturer are offered
How the Side Effects Stack Up
Ozempic (GLP-1 receptor agonist) and Rybelsus (GLP-1 receptor agonist) bring on much the same digestive side effects, which top the list of what patients report:
- Nausea (most common for both medications)
- Diarrhea and vomiting
- Constipation
- Abdominal pain
- Decreased appetite
- Headache, fatigue, dizziness (less common)
Rarer but more serious risks for both drugs include pancreatitis, gallbladder complications, and kidney strain. Each also carries a boxed warning about medullary thyroid carcinoma seen in rodent studies. Go over your complete medical history with a clinician before you start either one.
So Which One Is Right for You?
There is no single winner — the right pick comes down to your diagnosis, what your plan covers, how much weight you want to lose, and how you feel about injections versus pills. Use the quick checklist below as a starting point:
- -You have type 2 diabetes (on-label use, better insurance coverage)
- -Cost is a concern ($998/month at list price)
- -You prefer the convenience of once-weekly dosing
- -You have type 2 diabetes (on-label use, better insurance coverage)
- -You prefer an oral option over injections
- -Cost is a concern ($936/month at list price)
- -You prefer a daily dosing routine
See Who Prescribes These at the Lowest Price
Browse vetted telehealth programs that can prescribe Ozempic, Rybelsus, and other FDA-approved GLP-1 medications — ranked by what you will actually pay.
Common Questions, Answered
Can I switch from Ozempic to Rybelsus?
It can be done, but only under a prescriber's guidance, since Ozempic and Rybelsus rely on different active ingredients (Semaglutide vs Semaglutide (oral)). Your clinician will set the right starting dose and titration plan for whichever medication you move to.
Which is better for weight loss: Ozempic or Rybelsus?
Clinical data suggests Ozempic produces more weight loss on average (8-14% of body weight) compared to Rybelsus (5-10% of body weight). However, individual results vary significantly based on dosing, diet, exercise, and metabolic factors.
Is Ozempic cheaper than Rybelsus?
At list price, Rybelsus ($936/month) is less expensive than Ozempic ($998/month). With insurance, costs vary significantly. Ozempic: $25-$200/month typical copay. Rybelsus: $10-$150/month typical copay.
Do Ozempic and Rybelsus have the same side effects?
They overlap a lot. Stomach-related effects like nausea, diarrhea, vomiting, and constipation show up with both because they are typical of GLP-1 receptor agonists. That said, the different active ingredients mean how often and how strongly they hit can differ — talk through your history with a clinician to see which is the safer fit for you.
Does insurance cover Ozempic and Rybelsus?
Coverage varies by plan. Ozempic is FDA-approved for type 2 diabetes — insurance coverage is typically better for on-label use. Rybelsus is FDA-approved for type 2 diabetes. Check with your specific insurance plan and ask your doctor about prior authorization requirements.